Stage I-II non-small-cell lung cancer treated using either stereotactic ablative radiotherapy (SABR) or lobectomy by video-assisted thoracoscopic surgery (VATS): outcomes of a propensity score-matched analysis.
Citations
1,151 citations
548 citations
375 citations
Cites methods from "Stage I-II non-small-cell lung canc..."
...Reassuringly, in populations where a final diagnosis of benign disease is made in only 6% or less of resected tumours [27], the patterns of local control and disease recurrence were similar in SABR patients cohorts either with or without a preoperative diagnosis [28]....
[...]
302 citations
Cites result from "Stage I-II non-small-cell lung canc..."
...of patients 104 65 Age (y), median (range) 78 (59-90) 79 (50-91) <75 37 (36) 22 (34) 76-80 38 (37) 23 (35) 81 29 (28) 20 (31) Sex Male 77 (74) 45 (69) Female 27 (26) 20 (31) Histology Adenocarcinoma 50 (48) 40 (62) Squamous cell carcinoma 40 (38) 21 (32) Others 14 (14) 4 (6) ECOG performance status 0 49 (47) 43 (66) 1 46 (44) 20 (31) 2 9 (9) 2 (3) Smoking Yes 85 (82) 45 (69) No 19 (18) 20 (31) Tumor size (mm), median (range) 21 (9-30) 21 (10-30)...
[...]
...Additionally, several studies using propensity score matching showed comparable results between SBRT and surgery (22, 23)....
[...]
226 citations
References
52,293 citations
17,023 citations
15,624 citations
1,139 citations